Home Cart Sign in  
Chemical Structure| 122-48-5 Chemical Structure| 122-48-5

Structure of Zingerone
CAS No.: 122-48-5

Chemical Structure| 122-48-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Vanillylacetone is the key aroma constituents of ginger with anti-inflammatory, anti-oxidant, anti-cancerous, radioprotective and anti-microbial properties.

Synonyms: Vanillylacetone; Gingerone; AI3-31837

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Zingerone

CAS No. :122-48-5
Formula : C11H14O3
M.W : 194.23
SMILES Code : CC(CCC1=CC=C(O)C(OC)=C1)=O
Synonyms :
Vanillylacetone; Gingerone; AI3-31837
MDL No. :MFCD00048232
InChI Key :OJYLAHXKWMRDGS-UHFFFAOYSA-N
Pubchem ID :31211

Safety of Zingerone

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P280-P305+P351+P338-P304+P340-P405-P501

Related Pathways of Zingerone

pyroptosis

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HaCaT keratinocytes 100-200 μg/mL 0.5 or 3 hours Assessed cell viability under oxidative stress; THDC alone did not rescue viability, but THDC+AZ combination fully protected against H2O2-induced cell death Int J Mol Sci. 2021 Aug 15;22(16):8756
THP-1 macrophages 40 µM 24 hours To investigate the effect of zingerone on A. actinomycetemcomitans-induced NO production, results showed that zingerone significantly suppressed NO production. Biomedicines. 2023 Jul 28;11(8):2130
THP-1 macrophages 10-80 µM 24 hours To assess the cytotoxic effect of zingerone on THP-1 macrophages, results showed that zingerone did not induce any cytotoxicity at any concentration. Biomedicines. 2023 Jul 28;11(8):2130
Neonatal rat cardiomyocytes (NRCMs) 50 and 250 µM 24 hours Zingerone significantly suppressed PE-induced cardiomyocyte hypertrophy, reduced ANP and β-MHC mRNA expression levels, and decreased cell surface area. J Cell Mol Med. 2019 Sep;23(9):6466-6478
BE(2)-M17 cells 0.25 to 2 mM 24 or 48 hours Zingerone significantly suppressed cell viability in a dose-dependent manner; long-term treatment reduced colony-forming ability Int J Mol Sci. 2018 Sep 19;19(9):2832
BE(2)C cells 0.25 to 2 mM 24 or 48 hours Zingerone significantly suppressed cell viability in a dose-dependent manner Int J Mol Sci. 2018 Sep 19;19(9):2832
SH-SY5Y cells 0.25 to 2 mM 24 or 48 hours Zingerone significantly suppressed cell viability in a dose-dependent manner Int J Mol Sci. 2018 Sep 19;19(9):2832
RAW264.7 macrophage cells 200 µM 5 days To evaluate the effect of Zingerone on RAW264.7 cell differentiation. Results showed that Zingerone significantly inhibited osteoclast differentiation, as evidenced by reduced TRAP staining and activity (p < 0.05). Metabolites. 2024 Dec 9;14(12):693
SAOS-2 osteosarcoma cells 200 µM 7 and 14 days To evaluate the effect of Zingerone on SAOS-2 cell differentiation. Results showed that Zingerone significantly stimulated the gene expression of ALP and Runx2 (p < 0.05) but did not significantly enhance SAOS-2 mineralisation. Metabolites. 2024 Dec 9;14(12):693

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c mice Renca cell-induced tumor model Intraperitoneal injection 10 mg/kg Once daily for one week Zingerone significantly reduced tumor volume, decreased cyclin D1 expression, increased pH3-positive cells and apoptotic cells Int J Mol Sci. 2018 Sep 19;19(9):2832
C57BL/6 mice CFA-induced inflammatory pain model Intraperitoneal injection 10 mg/kg or 20 mg/kg Single dose or daily administration for 14 days To assess the analgesic effects of Zingerone on inflammatory pain, results showed that Zingerone significantly increased mechanical and thermal pain thresholds and reduced calcium signal activity in ACC neurons. Front Pharmacol. 2025 Mar 11;16:1543594
Male C57/B6J mice Aortic banding (AB) surgery-induced cardiac remodelling model Intragastric administration 10 or 20 mg/kg/day Once daily for 25 days Zingerone significantly suppressed AB surgery-induced cardiac hypertrophy, fibrosis, oxidative stress and inflammation, and improved cardiac function. J Cell Mol Med. 2019 Sep;23(9):6466-6478
BALB/c mice Pseudomonas aeruginosa peritonitis model Intraperitoneal 100 mg/kg Single dose To evaluate the hepatoprotective potential of zingerone against liver inflammation induced by antibiotic mediated endotoxemia in a P.aeruginosa peritonitis model. Results showed that zingerone significantly reduced liver inflammatory response, improved liver histology, and decreased levels of inflammatory markers (MDA, RNI, MPO) and cytokines (MIP-2, IL-6, and TNF-α). PLoS One. 2014 Sep 3;9(9):e106536
Wistar rats LPS-induced endotoxemia Oral 150 mg/kg Administered 2 h before LPS challenge and monitored up to 96 h post LPS treatment To evaluate the protective effect of Zingerone (ZIN) against lipopolysaccharide-induced oxidative stress, DNA damage, and cytokine storm in rats. Results showed that ZIN treatment significantly (p<0.5) restored plasma enzymes, antioxidant markers, and attenuated plasma proinflammatory cytokines and sepsis biomarker (PCT), thereby preventing multi-organ and tissue damage in LPS-induced rats, also confirmed by histopathological studies of different organs. Molecules. 2020 Nov 4;25(21):5127
Wistar rats Streptozotocin-induced diabetic model Oral 20 mg/kg Once daily for seven weeks Zingerone significantly suppressed delayed ventricular repolarization and AV conduction delay in diabetic rats, reducing cardiac fibrosis and inflammation. PLoS One. 2017 Dec 5;12(12):e0189074
Male swiss albino mice LiCl-and-pilocarpine-induced epilepsy model Oral 25 and 50 mg/kg Once daily for 15 days Zingerone attenuated seizure activity and protected hippocampal neurons by regulating redox imbalance, inflammation, and apoptosis Pharmaceuticals (Basel). 2021 Feb 11;14(2):146
Wistar rats Complete Freund’s adjuvant (FCA)-induced rheumatoid arthritis model Oral 25 mg/kg Once daily for 3 weeks To evaluate the protective role of zingerone in FCA-induced rheumatoid arthritis. Results showed that zingerone significantly reduced the levels of NF-κB, TGF-β, TNF-α, IL-1β, IL-6, and Hs-CRP and markedly increased IL-10 levels. The levels of antioxidant enzymes were also restored. Redox Rep. 2021 Dec;26(1):62-70
Sprague-Dawley rats Alcohol-induced fatty liver disease model Oral 40 mg/kg Daily administration from postnatal day 12 to 21 To evaluate the long-term protective effect of Zingerone against alcohol-induced fatty liver disease. Results showed that neonatal orally administered Zingerone attenuated alcohol-induced liver lipid accretion and SREBP1c upregulation in male rats only and attenuated the alcohol-induced hepatic PPAR-α downregulation and macrosteatosis in both sexes. Metabolites. 2023 Jan 23;13(2):167
C57BL/6 mice A. actinomycetemcomitans-induced periodontitis mice model Oral gavage 400 mg/kg Three times weekly for four weeks To evaluate the effect of zingerone on A. actinomycetemcomitans-induced alveolar bone resorption, results showed that zingerone significantly inhibited alveolar bone resorption. Biomedicines. 2023 Jul 28;11(8):2130
Wistar male albino rats Alloxan-induced diabetes model Oral 50 and 100 mg/kg Daily for 21 days Zingerone restrained the alloxan induced oxidative stress by increasing the activity of reduced glutathione (GSH), superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX) and reducing the peroxidative damage. We also confirmed that zingerone suppressed the level of redox-sensitive transcription factor NF-κB and downregulated other downstream inflammatory cytokines like interleukins (IL1-β, IL-2, IL-6) and tumor necrosis factor alpha (TNF-α). Moreover, the experimental findings suggested that zingerone improved the insulin levels. Saudi Pharm J. 2018 Dec;26(8):1137-1145
Wistar albino rats Carfilzomib-induced cardiotoxicity model Oral 50 mg/kg and 100 mg/kg 16 days Zingerone significantly attenuated the effects of CFZ on oxidative stress by enhancing the antioxidant properties of glutathione (GSH), catalase (CAT), and superoxide dismutase (SOD). Additionally, ZRN reduces inflammatory cytokines and apoptotic markers, such as IL-1β, IL-6, TNFα, and caspase-3. Overall, zingerone prevents carfilzomib-induced cardiotoxicity in rats, as evidenced by histopathological studies. Int J Mol Sci. 2022 Dec 9;23(24):15617

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.15mL

1.03mL

0.51mL

25.74mL

5.15mL

2.57mL

51.49mL

10.30mL

5.15mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories